MENU
+Compare
BLFS
Stock ticker: NASDAQ
AS OF
Apr 24, 04:59 PM (EDT)
Price
$24.78
Change
+$0.43 (+1.77%)
Capitalization
810.87M

BLFS BioLife Solutions Forecast, Technical & Fundamental Analysis

BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry... Show more

BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for BLFS with price predictions
Apr 23, 2025

BLFS sees its Stochastic Oscillator ascending out of oversold territory

On April 09, 2025, the Stochastic Oscillator for BLFS moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 53 instances where the indicator left the oversold zone. In of the 53 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BLFS's RSI Indicator exited the oversold zone, of 22 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on April 23, 2025. You may want to consider a long position or call options on BLFS as a result. In of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BLFS just turned positive on April 22, 2025. Looking at past instances where BLFS's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where BLFS advanced for three days, in of 325 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

BLFS moved below its 50-day moving average on March 25, 2025 date and that indicates a change from an upward trend to a downward trend.

The 50-day moving average for BLFS moved below the 200-day moving average on April 21, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BLFS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BLFS broke above its upper Bollinger Band on April 23, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for BLFS entered a downward trend on April 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BLFS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BLFS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.402) is normal, around the industry mean (23.728). P/E Ratio (238.095) is within average values for comparable stocks, (81.831). Projected Growth (PEG Ratio) (15.094) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (5.461) is also within normal values, averaging (41.794).

View a ticker or compare two or three
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

BLFS is expected to report earnings to rise 15.75% to -4 cents per share on May 08

BioLife Solutions BLFS Stock Earnings Reports
Q1'25
Est.
$-0.05
Q4'24
Beat
by $0.04
Q3'24
Beat
by $0.04
Q2'24
Missed
by $0.36
Q1'24
Beat
by $0.13
The last earnings report on March 03 showed earnings per share of -3 cents, beating the estimate of -7 cents. With 164.33K shares outstanding, the current market capitalization sits at 810.87M.
A.I. Advisor
published General Information

General Information

a manufacturer of proprietary and generic bio preservation media products for cells, tissues and organs

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
3303 Monte Villa Parkway
Phone
+1 425 402-1400
Employees
414
Web
https://www.biolifesolutions.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MIRGX36.00N/A
N/A
MFS Massachusetts Inv Gr Stk R2
INUTX35.95N/A
N/A
Columbia Dividend Opportunity A
TMMAX17.09N/A
N/A
SEI Tax-Managed Mgd Volatility F (SIMT)
TGRYX11.60N/A
N/A
TCW Global Real Estate N
SIMYX12.06N/A
N/A
SEI Tax-Managed Intl Mgd Vol Y (SIMT)

BLFS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BLFS has been loosely correlated with RGEN. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if BLFS jumps, then RGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLFS
1D Price
Change %
BLFS100%
+11.19%
RGEN - BLFS
55%
Loosely correlated
+1.78%
DHR - BLFS
47%
Loosely correlated
+2.21%
GH - BLFS
46%
Loosely correlated
+4.20%
VCYT - BLFS
46%
Loosely correlated
+1.08%
RVTY - BLFS
46%
Loosely correlated
+1.46%
More